Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-24

Clinical Trial Update: Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports on the efficacy of bromocriptine for fever reduction in acute neurologic injury across Phase 1 and Phase 2; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromocriptine (bromocriptine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Subarachnoid Hemorrhage, Subdural Hematoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-06-24